Indication
Acute lymphoid leukemia
Acute lymphoid leukemia, more commonly termed acute lymphoblastic or lymphocytic leukemia (ALL), is a fast-growing hematologic malignancy characterized by the clonal proliferation and accumulation of immature lymphoid progenitor cells (lymphoblasts) of B- or T-cell lineage. Read more about Acute lymphoid leukemia
509 drugs 215 manufacturers
Drugs that treat it
Common Acute lymphoid leukemia therapies.
READYSHARP DEXAMETHASONE (dexamethasone sodium phosphate)
CYTARABINE
METHOTREXATE (methotrexate sodium)
METHOTREXATE (methotrexate sodium)
METHOTREXATE (methotrexate sodium)
METHOTREXATE (methotrexate sodium)
PREDNISONE
PREDNISONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcute lymphoid leukemia, more commonly termed acute lymphoblastic or lymphocytic leukemia (ALL), is a fast-growing hematologic malignancy characterized by the clonal proliferation and accumulation of immature lymphoid progenitor cells (lymphoblasts) of B- or T-cell lineage.
The disease primarily targets the bone marrow and peripheral blood, frequently infiltrating extramedullary tissues such as the lymph nodes, spleen, liver, and central nervous system.
Although it can develop at any age, it is the most common childhood malignancy.
Pathophysiologically, the rapid overgrowth of leukemic blasts displaces normal hematopoietic precursors, leading to bone marrow failure typically manifested by anemia, thrombocytopenia, and neutropenia, which precipitate fatigue, bleeding, and recurrent infections.
- cancer.org
Acute lymphoid leukemia, more commonly termed acute lymphoblastic or lymphocytic leukemia (ALL), is a fast-growing hematologic malignancy characterized by the clonal proliferation and accumulation of immature lymphoid progenitor cells (lymphoblasts) of B- or T-cell lineage The disease primarily targets the bone marrow and peripheral blood, frequently infiltrating extramedullary tissues such as the lymph nodes, spleen, liver, and central nervous system
- nih.gov
Acute lymphoid leukemia, more commonly termed acute lymphoblastic or lymphocytic leukemia (ALL), is a fast-growing hematologic malignancy characterized by the clonal proliferation and accumulation of immature lymphoid progenitor cells (lymphoblasts) of B- or T-cell lineage The disease primarily targets the bone marrow and peripheral blood, frequently infiltrating extramedullary tissues such as the lymph nodes, spleen, liver, and central nervous system Pathophysiologically, the rapid overgrowth o...
- medlineplus.gov
Acute lymphoid leukemia, more commonly termed acute lymphoblastic or lymphocytic leukemia (ALL), is a fast-growing hematologic malignancy characterized by the clonal proliferation and accumulation of immature lymphoid progenitor cells (lymphoblasts) of B- or T-cell lineage Pathophysiologically, the rapid overgrowth of leukemic blasts displaces normal hematopoietic precursors, leading to bone marrow failure typically manifested by anemia, thrombocytopenia, and neutropenia, which precipitate fatig...
- cancer.gov
Although it can develop at any age, it is the most common childhood malignancy
- medlineplus.gov
Although it can develop at any age, it is the most common childhood malignancy
Personalize your experience
Follow Acute lymphoid leukemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.